Sessa Capital (Master), L.P.

Sessa Capital (Master), L.P. is a declared insider at 2 companies; the most frequent names are Provention Bio, Inc. and SAB Biotherapeutics, Inc. The record holds 10 filings, for trades running from 18 January 2023 to 29 September 2025.

Sales make up the whole of the open-market record (2 sales, €74.3M). The rest of the record consists of 1 share grant and 2 option exercises.

The record was last updated on 1 October 2025 with an option exercise (€2.6M) in SAB Biotherapeutics, Inc. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.